Bibliographic Details
| Title: |
CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells. |
| Authors: |
Hayden-Ledbetter MS; Trubion Pharmaceuticals, Inc., Seattle, Washington 98121, USA., Cerveny CG, Espling E, Brady WA, Grosmaire LS, Tan P, Bader R, Slater S, Nilsson CA, Barone DS, Simon A, Bradley C, Thompson PA, Wahl AF, Ledbetter JA |
| Source: |
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2009 Apr 15; Vol. 15 (8), pp. 2739-46. Date of Electronic Publication: 2009 Apr 07. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
